Search Results
Results found for "Ezequiel Marron Fernandez de Velasco"
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
✅ The sooner you understand what they’re optimizing for, the faster you can align your strategy to de-risk
- Therapeutic validation of an orphan G protein‐coupled receptor
Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance
- 📰 GPCR Weekly News, April 10 to 16, 2023
Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Learn how to transform your program from a series of disconnected efforts into a predictable, de-risked
- Advantages of Fluorescent Probes in GPCR Assays
Ciruela F, Jacobson KA, Fernández-Dueñas V.
- 📰 GPCR Weekly News, April 8 to 14, 2024
This week's highlight includes congrats to: Tessa de Vries, Graham Ladds, Antoinette MaassenVanDenBrink
- From DNA day to GPCR genomics
M., Pérez-Hernández, G., Batebi, H., Gao, Y., Eskici, G., Seven, A.
- 📰 GPCR Weekly News, March 27 to April 4, 2023
ended 31 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Bénard, G., Ramos, A., Reguero, L., Arrabal, S., Elezgarai, I., Gerrikagoitia, I., Suarez, J., Rodríguez De
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Van De Veen, W.; Akdis, M.; Ortega-Gutiérrez, S.; López-Rodríguez, M. L.; Akdis, C.
